Co-provided by:

The following programs offer highlights on valued information presented at the American Heart Association Scientific Sessions 2016 in New Orleans, Louisiana. Participate now to hear expert faculty discuss recent science and clinical strategies that impact the treatment of patients with dyslipidemia, heart failure and atrial fibrillation, respectively.

AHA 2016: Update on Lipid Lowering Therapies
1.0 AMA PRA Category 1 Credit

AHA 2016: Advances in the Management of Patients with Heart Failure
1.0 AMA PRA Category 1 Credit

An Update of Emerging Therapeutics to Prevent Stroke in Patients with Non-Valvular Atrial Fibrillation
1.0 AMA PRA Category 1 Credit

Group visibility: 
Public - accessible to all site users